BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Rowan PJ. Does prophylactic antidepressant treatment boost interferon-alpha treatment completion in HCV? World J Virol 2013; 2(4): 139-145 [PMID: 24255885 DOI: 10.5501/wjv.v2.i4.139]
URL: https://www.wjgnet.com/2220-3249/full/v2/i4/139.htm
Number Citing Articles
1
Zohaib Akhter, Olamide Todowede, Jennifer Valeska Elli Brown, Alexander Jarde, Laraib Mazhar, Venkata lakshmi narasimha, Sagir Muhammad, Sheraz Fazid, Khalid Rehman, Chetana Deshmukh, Akeemat Ayinla, Funmilola Wuraola, Mir Nabila Ashraf, Najma Siddiqi. Pharmacological interventions for depression in adults with chronic hepatitis B or CCochrane Database of Systematic Reviews 2022; 2022(8) doi: 10.1002/14651858.CD015037
2
Leila Kasraian, Neda Negarestani, Mohammad Hossein Karimi, Sahar Dehbidi. A Survey on the Prevalence of Depression in Blood Donors with Hepatitis C in ShirazHepatitis Monthly 2016; 16(11) doi: 10.5812/hepatmon.31080
3
Z. Younossi, L. Henry. Systematic review: patient-reported outcomes in chronic hepatitis C - the impact of liver disease and new treatment regimensAlimentary Pharmacology & Therapeutics 2015; 41(6): 497 doi: 10.1111/apt.13090